Deep data dive report examines factors and trends driving the infant and pregnant/breastfeeding women’s probiotics category and scrutinises increasingly online-engaged consumers and their often make-or-break role in product formulation strategies.More here. Deep data dive report examines factors and trends driving the infant and pregnant/breastfeeding women’s probiotics category and scrutinises increasingly online-engaged consumers and their often make-or-break role in product formulation strategies.More here.
Deep data dive report examines factors and trends driving the infant and pregnant/breastfeeding women’s probiotics category and scrutinises increasingly online-engaged consumers and their often make-or-break role in product formulation strategies.
More here.
Deep data dive report examines factors and trends driving the infant and pregnant/breastfeeding women’s probiotics category and scrutinises increasingly online-engaged consumers and their often make-or-break role in product formulation strategies.
More here.
Extract:
Kate Allan, British 50 Mile Time Trial Champion in 2017 and founder of endurance sports communications firm, Compete PR, developed COVID-19 symptoms back in March.
“Three weeks in, with symptoms becoming more intense, I ended up in A&E – breathless, with a horribly mucous-y cough and body aches like no other,” she wrote of her COVID-19 experience.
“…the chest x-ray showed pneumonia in my right lung and the blood tests markers of infection.”
...
Coming down with COVID-19 prompted her to alter her eating patterns and views of nutrition.
“I’ve started taking magnesium, vitamin D and a more general multi-vitamin, and being more mindful about taking onboard healthier foods…My skin is brighter, and although I’ve felt pretty dreadful with lurgy – I can feel that my body is functioning far more effectively than it has been.”
Full story here.
According to the International Society of Sports Nutrition (ISSN) in a lengthy position paper published at the end of 2019 in its eponymous research journal the answer is ‘yes’. But it called for more research and noted the overall research base provides only ‘modest evidence’.
What it made clear though was that the best results come from using the right strains at the right doses. ISSN said the research review that formed the basis of its position paper was complicated “by variations in clinical outcome measures and most importantly, as probiotic benefits are strain-specific, by different strains used in these studies.”
Full story here.
